• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素中抗凝血酶结合序列的延伸及结构变异性

Extension and structural variability of the antithrombin-binding sequence in heparin.

作者信息

Lindahl U, Thunberg L, Bäckström G, Riesenfeld J, Nordling K, Björk I

出版信息

J Biol Chem. 1984 Oct 25;259(20):12368-76.

PMID:6490618
Abstract

Oligosaccharides with different affinities for antithrombin were isolated following partial deaminative cleavage of pig mucosal heparin with nitrous acid. The smallest high-affinity component obtained was previously identified as an octasaccharide with the predominant structure: (Formula: see text). The interaction of this octasaccharide, and of deca- and dodecasaccharides containing the same octasaccharide sequence, with antithrombin was studied by spectroscopic techniques. The near-ultraviolet difference spectra, circular dichroism spectra, and fluorescence enhancements induced by adding these oligosaccharides to antithrombin differed only slightly from the corresponding parameters measured in the presence of undegraded high-affinity heparin. Moreover, the binding constants obtained for the oligosaccharides and for high-affinity heparin were similar (1.0-2.9 X 10(7) M-1 at I = 0.3). In contrast, two hexasaccharides corresponding to units 1-6 and 3-8, respectively, of the above sequence showed about a 1000-fold lower affinity for antithrombin, and also induced considerably different spectral perturbations in antithrombin. Since the 1-6 hexasaccharide contains a reducing-terminal anhydromannose residue instead of the N-sulfated glucosamine unit 6 of the intact sequence, these results strongly support our previous conclusion that the N-sulfate group at position 6 is essential to the interaction with antithrombin. The low affinity of the hexasaccharide 3-8 provides further evidence that a pentasaccharide sequence 2-6 constitutes the actual antithrombin-binding region in the heparin molecule. Structural analysis of the various oligosaccharides revealed natural variants with an N-sulfate group substituted for the N-acetyl group at position 2. The preponderance of N-acetyl over N-sulfate groups at this position may be rationalized in terms of the mechanism of heparin biosynthesis, assuming that the D-gluco configuration of unit 3 is an essential feature of the antithrombin-binding region.

摘要

用亚硝酸对猪黏膜肝素进行部分脱氨基裂解后,分离出了对抗凝血酶具有不同亲和力的寡糖。所得到的最小的高亲和力组分先前已被鉴定为一种主要结构为(化学式:见原文)的八糖。通过光谱技术研究了这种八糖以及含有相同八糖序列的十糖和十二糖与抗凝血酶的相互作用。将这些寡糖添加到抗凝血酶中所诱导的近紫外差光谱、圆二色光谱和荧光增强,与在未降解的高亲和力肝素存在下测得的相应参数相比,仅有轻微差异。此外,寡糖和高亲和力肝素的结合常数相似(在离子强度I = 0.3时为1.0 - 2.9×10⁷ M⁻¹)。相比之下,分别对应于上述序列的1 - 6单元和3 - 8单元的两种六糖对抗凝血酶的亲和力低约1000倍,并且在抗凝血酶中也诱导出明显不同的光谱扰动。由于1 - 6六糖含有一个还原端脱水甘露糖残基,而不是完整序列中的N - 硫酸化葡糖胺单元6,这些结果有力地支持了我们先前的结论,即6位的N - 硫酸基团对于与抗凝血酶的相互作用至关重要。3 - 8六糖的低亲和力进一步证明了五糖序列2 - 6构成了肝素分子中实际的抗凝血酶结合区域。对各种寡糖的结构分析揭示了在2位存在N - 硫酸基团取代N - 乙酰基团的天然变体。假设单元3的D - 葡糖构型是抗凝血酶结合区域的一个基本特征,那么从肝素生物合成机制的角度来看,该位置N - 乙酰基团相对于N - 硫酸基团的优势可能是合理的。

相似文献

1
Extension and structural variability of the antithrombin-binding sequence in heparin.肝素中抗凝血酶结合序列的延伸及结构变异性
J Biol Chem. 1984 Oct 25;259(20):12368-76.
2
Further characterization of the antithrombin-binding sequence in heparin.肝素中抗凝血酶结合序列的进一步表征。
Carbohydr Res. 1982 Mar 1;100:393-410. doi: 10.1016/s0008-6215(00)81050-2.
3
The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group.肝素中抗凝血酶结合序列。一个必需的6-O-硫酸基团的鉴定。
J Biol Chem. 1983 Aug 25;258(16):9826-30.
4
Biosynthesis of heparin. O-sulfation of the antithrombin-binding region.肝素的生物合成。抗凝血酶结合区域的O-硫酸化。
J Biol Chem. 1988 Oct 25;263(30):15474-84.
5
Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.肝素抗凝血酶结合序列中存在3-O-硫酸化D-葡萄糖胺残基的证据。
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6551-5. doi: 10.1073/pnas.77.11.6551.
6
An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.一种具有活性五糖序列中额外的 3-O-硫酸化葡萄糖胺的非典型抗凝血酶结合肝素八糖。
Biochem J. 2013 Jan 15;449(2):343-51. doi: 10.1042/BJ20121309.
7
Location of the antithrombin-binding sequence in the heparin chain.抗凝血酶结合序列在肝素链中的位置。
J Biol Chem. 1989 Jan 5;264(1):296-304.
8
Contribution of monosaccharide residues in heparin binding to antithrombin III.肝素中与抗凝血酶III结合的单糖残基的作用
Biochemistry. 1985 Nov 5;24(23):6723-9. doi: 10.1021/bi00344a063.
9
Sequence variation in heparin octasaccharides with high affinity for antithrombin III.对抗凝血酶III具有高亲和力的肝素八糖中的序列变异。
Biochemistry. 1984 Nov 20;23(24):5801-12. doi: 10.1021/bi00319a020.
10
1H NMR spectroscopic studies on the interactions between human plasma antithrombin III and defined low molecular weight heparin fragments.关于人血浆抗凝血酶III与特定低分子量肝素片段之间相互作用的核磁共振氢谱研究。
Biochemistry. 1992 Mar 3;31(8):2286-94. doi: 10.1021/bi00123a011.

引用本文的文献

1
Relation between antithrombin-III activity and activated clotting time for cardiopulmonary bypass.体外循环中抗凝血酶III活性与活化凝血时间的关系。
J Artif Organs. 2025 Jun;28(2):216-224. doi: 10.1007/s10047-024-01462-y. Epub 2024 Aug 2.
2
Differential Solvent DEEP-STD NMR and MD Simulations Enable the Determinants of the Molecular Recognition of Heparin Oligosaccharides by Antithrombin to Be Disentangled.差溶剂深度等温核磁和分子动力学模拟解析肝素寡糖与抗凝血酶分子识别的决定因素。
Int J Mol Sci. 2024 Apr 25;25(9):4669. doi: 10.3390/ijms25094669.
3
Interactions of proteins with heparan sulfate.
蛋白质与硫酸乙酰肝素的相互作用。
Essays Biochem. 2024 Dec 4;68(4):479-489. doi: 10.1042/EBC20230093.
4
Purification and characterisation of heparin-like sulfated polysaccharides with potent anti-SARS-CoV-2 activity from snail mucus of Achatina fulica.从非洲大蜗牛黏液中提取具有抗 SARS-CoV-2 活性的肝素样硫酸化多糖的纯化和特性研究。
Carbohydr Res. 2023 Jul;529:108832. doi: 10.1016/j.carres.2023.108832. Epub 2023 May 11.
5
Not Just Anticoagulation-New and Old Applications of Heparin.肝素的新老应用:不止抗凝。
Molecules. 2022 Oct 17;27(20):6968. doi: 10.3390/molecules27206968.
6
Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression.硫酸乙酰肝素生物合成与硫酸化谱作为癌症信号传导和进展的调节因子
Front Oncol. 2021 Nov 11;11:778752. doi: 10.3389/fonc.2021.778752. eCollection 2021.
7
Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants.肝素、维生素K拮抗剂及直接口服抗凝剂抗凝治疗进展与实验室监测工具
Biomedicines. 2021 Mar 7;9(3):264. doi: 10.3390/biomedicines9030264.
8
Effect of Carboxymethylation and Phosphorylation on the Properties of Polysaccharides from Sepia esculenta Ink: Antioxidation and Anticoagulation in Vitro.乌贼墨多糖的羧甲基化和磷酸化改性及其体外抗氧化和抗凝血活性研究。
Mar Drugs. 2019 Nov 1;17(11):626. doi: 10.3390/md17110626.
9
SAX-HPLC and HSQC NMR Spectroscopy: Orthogonal Methods for Characterizing Heparin Batches Composition.二维液相色谱和异核单量子相干核磁共振波谱法:用于表征肝素批次组成的正交方法。
Front Med (Lausanne). 2019 Apr 18;6:78. doi: 10.3389/fmed.2019.00078. eCollection 2019.
10
Heparin: role in protein purification and substitution with animal-component free material.肝素:在蛋白质纯化中的作用以及用无动物成分材料替代。
Appl Microbiol Biotechnol. 2018 Oct;102(20):8647-8660. doi: 10.1007/s00253-018-9263-3. Epub 2018 Aug 9.